209 related articles for article (PubMed ID: 3948153)
1. Transport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate.
Henderson GB; Suresh MR; Vitols KS; Huennekens FM
Cancer Res; 1986 Apr; 46(4 Pt 1):1639-43. PubMed ID: 3948153
[TBL] [Abstract][Full Text] [Related]
2. Transport of folate compounds by leukemic cells. Evidence for a single influx carrier for methotrexate, 5-methyltetrahydrofolate, and folate in CCRF-CEM human lymphoblasts.
Henderson GB; Tsuji JM; Kumar HP
Biochem Pharmacol; 1987 Sep; 36(18):3007-14. PubMed ID: 3477231
[TBL] [Abstract][Full Text] [Related]
3. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
[TBL] [Abstract][Full Text] [Related]
4. Relationships between carrier-mediated transport of folate compounds by L1210 leukemia cells: evidence for multiplicity of entry routes with different kinetic properties expressed in plasma membrane vesicles.
Yang CH; Dembo M; Sirotnak FM
J Membr Biol; 1983; 75(1):11-20. PubMed ID: 6887234
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells.
Henderson GB; Strauss BP
Cancer Res; 1990 Mar; 50(6):1709-14. PubMed ID: 2306724
[TBL] [Abstract][Full Text] [Related]
6. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling.
Yang CH; Sirotnak FM; Mines LS
J Biol Chem; 1988 Jul; 263(20):9703-9. PubMed ID: 2838477
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
Sirotnak FM; Poser RE; Barrueco JR
Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
[TBL] [Abstract][Full Text] [Related]
8. Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.
Fry DW; Besserer JA; Boritzki TJ
Cancer Res; 1984 Aug; 44(8):3366-70. PubMed ID: 6547636
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the individual transport routes that mediate the influx and efflux of methotrexate in CCRF-CEM human lymphoblastic cells.
Henderson GB; Tsuji JM; Kumar HP
Cancer Res; 1986 Apr; 46(4 Pt 1):1633-8. PubMed ID: 3948152
[TBL] [Abstract][Full Text] [Related]
10. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
Sierra EE; Goldman ID
Biochem Pharmacol; 1998 May; 55(9):1505-12. PubMed ID: 10076544
[TBL] [Abstract][Full Text] [Related]
11. Expression of a folate binding protein in L1210 cells grown in low folate medium.
Jansen G; Kathmann I; Rademaker BC; Braakhuis BJ; Westerhof GR; Rijksen G; Schornagel JH
Cancer Res; 1989 Apr; 49(8):1959-63. PubMed ID: 2702638
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the multiple transport routes for methotrexate in L1210 cells using phthalate as a model anion substrate.
Henderson GB; Zevely EM
J Membr Biol; 1985; 85(3):263-8. PubMed ID: 3897547
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of folate transport in rabbit reticulocytes.
Bobzien WF; Goldman ID
J Clin Invest; 1972 Jul; 51(7):1688-96. PubMed ID: 5032520
[TBL] [Abstract][Full Text] [Related]
14. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Jul; 273(30):19065-71. PubMed ID: 9668089
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Spinella MJ; Brigle KE; Sierra EE; Goldman ID
J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
[TBL] [Abstract][Full Text] [Related]
16. 5,10-Dideazatetrahydrofolic acid (DDATHF) transport in CCRF-CEM and MA104 cell lines.
Pizzorno G; Cashmore AR; Moroson BA; Cross AD; Smith AK; Marling-Cason M; Kamen BA; Beardsley GP
J Biol Chem; 1993 Jan; 268(2):1017-23. PubMed ID: 8419310
[TBL] [Abstract][Full Text] [Related]
17. Affinity labeling of the 5-methyltetrahydrofolate/methotrexate transport protein of L1210 cells by treatment with an N-hydroxysuccinimide ester of [3H]methotrexate.
Henderson GB; Zevely EM
J Biol Chem; 1984 Apr; 259(7):4558-62. PubMed ID: 6707019
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
Jansen G; Westerhof GR; Jarmuszewski MJ; Kathmann I; Rijksen G; Schornagel JH
J Biol Chem; 1990 Oct; 265(30):18272-7. PubMed ID: 2211701
[TBL] [Abstract][Full Text] [Related]
19. Transport of folate compounds, pterins and adenine in L1210 mouse leukemia cells.
Huennekens FM; Suresh MR; Vitols KS; Henderson GB
Adv Enzyme Regul; 1982; 20():389-408. PubMed ID: 7113803
[TBL] [Abstract][Full Text] [Related]
20. Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo.
Sirotnak FM; Goutas LJ; Mines LS
Cancer Res; 1985 Oct; 45(10):4732-4. PubMed ID: 3875399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]